Clover Health Investments Corp (NASDAQ: CLOV) is 178.33% higher on its value in year-to-date trading and has touched a low of $0.61 and a high of $3.82 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLOV stock was last observed hovering at around $2.54 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $2.65, the stock is -7.25% and 25.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.69 million and changing 4.33% at the moment leaves the stock 118.14% off its SMA200. CLOV registered 96.30% gain for a year compared to 6-month gain of 245.28%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 41.71% loss in the last 1 month and extending the period to 3 months gives it a 157.28%, and is -7.50% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.55% over the week and 12.05% over the month.
Clover Health Investments Corp (CLOV) has around 552 employees, a market worth around $1.32B and $1.69B in sales. Profit margin for the company is -7.32%. Distance from 52-week low is 337.29% and -30.54% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.78%).
The EPS is expected to grow by 71.35% this year
149.0 institutions hold shares in Clover Health Investments Corp (CLOV), with institutional investors hold 20.46% of the company’s shares. The shares outstanding are 393.27M, and float is at 375.64M with Short Float at 7.81%. Institutions hold 18.59% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 17.35 million shares valued at $21.33 million. The investor’s holdings represent 3.5662 of the CLOV Shares outstanding. As of 2024-06-30, the second largest holder is RENAISSANCE TECHNOLOGIES LLC with 11.27 million shares valued at $13.86 million to account for 2.3176 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 9.54 million shares representing 1.9613 and valued at over $11.73 million, while PNC FINANCIAL SERVICES GROUP, INC. holds 1.0302 of the shares totaling 5.01 million with a market value of $6.16 million.
Clover Health Investments Corp (CLOV) Insider Activity
The most recent transaction is an insider purchase by Garipalli Vivek, the company’s Director. SEC filings show that Garipalli Vivek bought 531,700 shares of the company’s common stock on Aug 09 ’24 at a price of $1.88 per share for a total of $1.0 million. Following the purchase, the insider now owns 1.41 million shares.
Clover Health Investments Corp disclosed in a document filed with the SEC on Jun 17 ’24 that Garipalli Vivek (Director) bought a total of 877,567 shares of the company’s common stock. The trade occurred on Jun 17 ’24 and was made at $1.14 per share for $1.0 million. Following the transaction, the insider now directly holds 0.88 million shares of the CLOV stock.
Still, SEC filings show that on May 16 ’24, Loengard Anna U (Director) acquired 17,085 shares at an average price of $0.96 for $16372.0. The insider now directly holds 15,600 shares of Clover Health Investments Corp (CLOV).
